Specific Oncolytic Effect of a New Hypoxia-Inducible Factor-Dependent Replicative Adenovirus on von Hippel-Lindau-Defective Renal Cell Carcinomas

Cancer Research

Volumn 63, Issue 20, 2003, Pages 6877-6884

  Cuevas, Yolanda ^a   Hernández Alcoceba, Rubén ^b   Aragones, Julian ^a,c   Naranjo Suárez, Salvador ^a   Castellanos, María C ^a   Esteban, Miguel A ^a   Martín Puig, Silvia ^a   Landazuri, Manuel O ^a   Del Peso, Luis ^a  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^b UNIVERSITY OF NAVARRA   (Spain)

^c DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; ALPHA TUBULIN; HYPOXIA INDUCIBLE FACTOR 1ALPHA; HYPOXIA INDUCIBLE FACTOR 1BETA; MESSENGER RNA; ONCOLYTIC VIRUS; PROTEASOME; TRANSCRIPTION FACTOR; UBIQUITIN; UNCLASSIFIED DRUG; VASCULOTROPIN; VIRUS PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CLEAR CELL CARCINOMA; CONTROLLED STUDY; CYTOLYSIS; GENE INDUCTION; HETEROZYGOSITY LOSS; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; KIDNEY CARCINOMA; MOUSE; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; PROMOTER REGION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR SUPPRESSOR GENE; VIRUS REPLICATION; VON HIPPEL LINDAU GENE;

ADENOVIRUS E1A PROTEINS; ADENOVIRUSES, HUMAN; BASE SEQUENCE; CARCINOMA, RENAL CELL; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; KIDNEY NEOPLASMS; MOLECULAR SEQUENCE DATA; PROMOTER REGIONS (GENETICS); TRANSCRIPTION FACTORS; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEINS; UBIQUITIN-PROTEIN LIGASES; VIRUS REPLICATION; VON HIPPEL-LINDAU TUMOR SUPPRESSOR PROTEIN;

EID: 0142157670     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Lando, D., Gorman, J. J., White, M. F., and Peel, D. J. Oxygen-dependent regulation of hypoxia-inducible factors by prolyl and asparaginyl hydroxylation. Eur. J. Immunol., 270: 781-790, 2003.
2. Seagroves, T., and Johnson, R. S. Two HIFs may be better than one. Cancer Cell, 1: 211-213, 2002.
3. Mack, F. A., Rathmell, W. K., Arsham, A. M., Gnarra, J., Keith, Kcith, B., and Simon, M. C. Loss of pVHL is sufficient to cause HIF dysregulation in primary cells but does not promote tumor growth. Cancer Cell, 3: 75-88, 2003.
4. Krishnamachary, B., Berg-Dixon, S., Kelly, B., Agani, F., Feldser, D., Ferreira G., Iyer, N., LaRusch, J., Pak, B., Taghavi, P., and Semenza, G. L. Regulation of colon carcinoma cell invasion by hypoxia-inducible factor I. Cancer Res., 63: 1138-1143, 2003.
5. Biederer, C., Ries, S., Brandts, C., and MaCormiek, F. Replication-selective viruses for cancer therapy. J. Mol. Med., 80: 163-175, 2002.
6. Kruyt, F. A., and Curiel, D. T. Toward a new generation of conditionally replicating adenoviruses: pairing tumor selectivity with maximal oncolysis. Hum. Gene Ther., 13: 485-495, 2002.
7. Hernandez-Alcoceba, R., Pihalja, M., Qian, D., and Clarke, M. F. New oncolytic adenovirus with hypoxia- and estrogen receptor-regulated replication, Hum. Gene Ther., 13: 1737-1750, 2002.
8. Hernandez-Alcoceba, R., Pihalja, M., Wicha, M. S., and Clarke, M. F. A novel, conditionally replicative adenovirus for the treatment of breast cancer that allows controlled replication of E1a-deleted adenoviral vectors. Hum. Gene Ther., 11: 2009-2024, 2000.
9. Hernandez-Aleoceba, R., Pihalja, M., Nunez, G., and Clarke, M. F. Evaluation of a new dual-specificity promoter for selective induction of apoptosis in breast cancer cells. Cancer Gene Ther., 8: 298-307, 2001.
10. Flint, J., and Shenk, T. Viral transactivating proteins. Annu. Rev. Genet., 31: 177-212, 1997.
11. Munoz, C., Castellanos, M. C., Alfranca, A., Vara, A., Esteban, M. A., Redondo, J. M., and de Landazuri, M. O. Transcriptional up-regulation of intracellular adhesion molecule-I in human endothelial cells by the antioxidant pyrrolidine dithiocarbamate involves the activation of activating protein-1. J. Immunol., 157: 3587-3597, 1996.
12. Aragones, J., Jones, D. R., Martin, S., San Juan, M. A., Alfranca, A., Vidal, F., Vara, A., Merida, I., and Landazuri, M. O. Evidence for the involvement of diacylglycerol kinase in the activation of hypoxia-inducible transcription factor 1 by low oxygen tension. J. Biol. Chem., 276: 10548-10555, 2001.
13. Williams, R. D., Elliott, A. Y., Stein, N., and Fraley, E. E. In vitro cultivation of human renal cell cancer. I. Establishment of cells in culture. In Vitro (Rockville), 12: 623-627, 1976.
14. Iliopoulos, O., Kibel, A., Gray, S., and Kaelin, W. G. J. Tumour suppression by the human von Hippel-Lindau gene product. Nat. Med., 1: 822-826, 1995.
15. Krieg, M., Haas, R., Brauch, H., Acker, T., Flamme, I., and Plate, K. H. Up-regulation of hypoxia-inducible factors HIF-1α and HIF-2α under normoxic conditions in renal carcinoma cells by von Hippel-Lindau tumor suppressor gene loss of function. Oncogene, 19: 5435-5443, 2000.
16. Grossman, H. B., Wedemeyer, G., and Ren, L. Q. Human renal carcinoma: characterization of five new cell lines. J. Surg. Oncol., 28: 237-244, 1985.
17. Ivanov, S. V., Kuzmin, I., Wei, M. H., Pack, S., Geil, L., Johnson, B. E., Stanbridge, E. J., and Lerman, M. I. Down-regulation of transmembrane carbonic anhydrases in renal cell carcinoma cell lines by wild-type von Hippel-Lindau transgenes. Proc. Natl. Acad. Sci. USA, 95: 12596-12601, 1998.
18. Maxwell, P. H., Wiesener, M. S., Chang, G. W., Clifford, S. C., Vaux, E. C., Cockman, M. E., Wykoff, C. C., Pugh, C. W., Maher, E. R., and Ratcliffe, P. J. The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis [see comments]. Nature (Lond.), 399: 271-275, 1999.
19. Iliopoulos, O., Levy, A. P., Jiang, C., Kaelin, W. G. J., and Goldberg, M. A. Negative regulation of hypoxia-inducible genes by the von Hippel-Lindau protein. Proc. Natl. Acad. Sci. USA, 93: 10595-10599, 1996.
20. Alvarez-Tejado, M., Alfraaca, A., Aragones, J., Vara, A., Landazuri, M. O., and del Peso, L. Lack of evidence for the involvement of the phosphoinositide 3-kinase/Akt pathway in the activation of hypoxia-inducible factors by low oxygen tension. J. Biol. Chem., 28: 13508-13517, 2002.
21. Estebzn-Barragan, M. A., Avila, P., Alvarez-Tejado, M., Gutierrez, M. D., Garcia-Pardo, A., Sanchez-Madrid, F., and Landazuri, M. O. Role of the von Hippel-Lindau tumor suppressor gene in the formation of β1-integrin fibrillar adhesions. Cancer Res., 62: 29229-29236, 2002.
22. Zhong, H., Agani, F., Baccala, A. A., Laughner, E., Rioseco-Camaeho, N., Isaacs, W. B., Simons, J. W., and Semenza, G. L. Increased expression of hypoxia-inducible factor 1α in rat and human prostate cancer. Cancer Res., 58: 5280-5284, 1998.
23. Talks, K. L., Turley, H., Gatter, K. C., Maxwell, P. H., Pugh, C. W., Ratcliffe, P. J., and Harris, A. L. The expression and distribution of the hypoxia-inducible factors HIF-1α and HIF-2α in normal human tissues, cancers, and tumor-associated macrophages. Am. J. Pathol., 157: 411-421, 2000.
24. Wiesener, M. S., Jorgensen, J. S., Rosenberger, C., Scholze, C. K., Horstrup, J. H., Warnecke, C., Mandriola, S., Bechmann, I., Frei, U. A., Pugh, C. W., Ratcliffe, P. J., Bachmann, S., Maxwell, P. H., and Eckardt, K. U. Widespread hypoxia-inducible expression of HIF-2α in distinct cell populations of different organs. FASEB J., 17: 271-273, 2003.
25. Stroka, D. M., Bnrkhardt, T., Desbaillets, I., Wenger, R. H., Neil, D. A., Bauer, C., Gassmann, M., and Candinas, D. HIF-1 is expressed in normoxie tissue and displays an organ-specific regulation under systemic hypoxia. FASEB J., 15: 2445-2453, 2001.
26. Zhong, H., De Marzo, A. M., Laughner, E., Lim, M., Hilton, D. A., Zagzag, D., Bucchler, P., Isaacs, W. B., Semenza, G. L., and Simons, J. W. Overexpression of hypoxia-inducible factor 1α in common human cancers and their metastases. Cancer Res., 59: 5830-5835, 1999.
27. Zundel, W., Sehindler, C., Haas-kogan, D., Koong, A., Kraper, F., Chen, E., Gottschalk, A. R., Ryan, H. E., Johnson, R. S., Jefferson, A. B., Stokoe, D., and Giaecia, A. J. Loss of PTEN facilitates HIF-1-mediated gene expression. Genes Dev., 14: 391-396, 2000.
28. Semenza, G. L. Hypoxia, clonal selection, and the role of HIF-1 in tumor progression. Crit. Rev. Biochem. Mol. Biol., 35: 71-103, 2000.
29. Dawn, E. P., and van Meir, E. G. A novel hypoxia-inducible factor (HIF)-activated oncolytic adenovirus for cancer therapy. Oncogene, 22: 2065-2072, 2003.